In 2019, it received FDA approval for reducing the risk of major cardiovascular events in individuals with both diabetes and a history of cardiovascular issues
1GLP-1 medications like Ozempic and Wegovy may reduce alcohol cravings based on new clinical trial data 2A JAMA Psychiatry study found semaglutide reduced drinking quantity, cravings, and heavy drinking days 3GLP-1 drugs are NOT yet FDA-approved for treating alcohol use disorder 4Current FDA-approved alcohol addiction medications (naltrexone, acamprosate, disulfiram) are available and effective 5Medical detox with 24/7 supervision is the safest way to stop drinking If you've been following health news lately, you've likely heard about Ozempic and Wegovy, the blockbuster medications originally developed for diabetes and weight loss
They broke down the key provisions of the CAA 2026 PBM reforms, explored the DOLs proposed rule and its implications for plan sponsors and PBMs, examined recent FTC settlements, and assessed how the administrations drug pricing initiatives might shape the market going forward
The reagent is an i
Turns down hunger signals Acts on the brain's appetite pathways, easing the steady pull toward unconscious snacking and overeating
CEO Names Missing: Its surprising that 45 out of 96 DDAs dont have a named Chief Executive Officer (CEO)